Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
N03AX12	APO-GABAPENTIN	G	Gabapentin - 300mg	300mg	Capsule	2,527,768 L.L
L01EB01	APO-GEFITINIB	G	Gefitinib - 250mg	250mg	Tablet	87,345,820 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
A10BB12	AMARYL	B	Glimepiride - 1mg	1mg	Tablet	231,141 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 1mg	1mg	Tablet	137,072 L.L
A10BB12	AMARYL	B	Glimepiride - 2mg	2mg	Tablet	233,829 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 2mg	2mg	Tablet	139,760 L.L
A10BB12	AMARYL	B	Glimepiride - 3mg	3mg	Tablet	392,402 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 3mg	3mg	Tablet	215,015 L.L
A10BB12	AMARYL	B	Glimepiride - 4mg	4mg	Tablet	392,402 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 4mg	4mg	Tablet	215,015 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
B05AA01	ALBUTEIN	BioHuman	Human Albumin - 20%	20%	Injectable solution	7,154,928 L.L
B05AA01	ALBUTEIN	BioHuman	Human Albumin - 20%		Injectable solution	4,031,528 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	36,492,913 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
M05BA06	ADROMUX	G	Ibandronic acid - 150mg	150mg	Tablet, coated	821,088 L.L
M01AE01	ADVIL	B	Ibuprofen - 200mg	200mg	Tablet	321,178 L.L
M01AE01	ADVIL LIQUI-GELS	B	Ibuprofen - 200mg	200mg	Capsule	464,970 L.L
M01AE51	ADVIL COLD & SINUS	B	Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg		Caplet, coated	288,926 L.L
M01AE01	ADVIL LIQUI-GELS EXTRA STRENGTH	B	Ibuprofen - 400mg	400mg	Capsule	575,165 L.L
N02AJ08	ASTEFOR	G	Ibuprofen - 400mg, Codeine phosphate hemihydrate - 30mg		Tablet, film coated	935,314 L.L
M01AE01	ALGIFAST PEDIATRIC	B	Ibuprofen Lysine - 20mg/ml	20mg/ml	Suspension	393,746 L.L
M01AE01	ALGIFAST 400	B	Ibuprofen Lysine - 400mg	400mg	Powder for suspension	473,033 L.L
L01EA01	APO-IMATINIB	G	Imatinib - 100mg	100mg	Tablet	38,330,537 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
A10AB01	ACTRAPID	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	752,552 L.L